Clara Amalie Gade Timmermann1,2, Marianne Skovsager Andersen3, Esben Budtz-Jørgensen4, Henriette Boye5, Flemming Nielsen1, Richard Christian Jensen1,3, Signe Bruun6,7, Steffen Husby6, Philippe Grandjean1,8, Tina Kold Jensen1,5,9. 1. Research Unit of Clinical Pharmacology, Pharmacy and Environmental Medicine, University of Southern Denmark, Odense, Denmark. 2. Department of Public Health, University of Copenhagen, Copenhagen, Denmark. 3. Department of Endocrinology, Odense University Hospital, Odense, Denmark. 4. Section of Biostatistics, University of Copenhagen, Copenhagen, Denmark. 5. Odense Child Cohort, Hans Christian Andersen Children's Hospital, Odense University Hospital, Odense, Denmark. 6. Hans Christian Andersen Children's Hospital, Odense University Hospital and University of Southern Denmark, Odense, Denmark. 7. Strategic Business Unit Pediatric, Arla Foods Ingredients Group P/S, Viby J, Denmark. 8. Department of Environmental Health, Harvard T.H. Chan School of Public Health, Boston, United States. 9. Open Patient data Exploratory Network (OPEN), Odense University Hospital, Odense, Denmark.
Abstract
CONTEXT: Human exposure to perfluoroalkyl substances (PFAS) has been associated with reduced duration of breastfeeding, although not consistently so, and mechanisms by which PFAS might affect breastfeeding are unknown. OBJECTIVE: To examine the association between early pregnancy serum-PFAS concentrations and breastfeeding termination and to elucidate the potential role of serum-prolactin concentrations in pregnancy. MATERIALS AND METHODS: Pregnant women from the Odense Child Cohort provided blood samples for analysis of 5 major PFAS (n = 1300) and prolactin concentrations (n = 924). They subsequently provided information about the duration of breastfeeding in questionnaires at 3 and 18 months postpartum, and a subgroup also provided breastfeeding information via weekly cell phone text messages. Associations between serum-PFAS concentrations and breastfeeding termination were analyzed using Cox regressions, while linear regression was used to assess associations between serum-PFAS and prolactin concentrations. RESULTS: Increased serum concentrations of perfluorooctane sulfonic acid, perfluorooctanoic acid, perfluorononanoic acid, and ∑PFAS were associated with a 16% (95% CI: 4%-30%), 14% (95% CI: 2%-26%), 14% (95% CI: 3%-27%), and 20% (95% CI: 6%-36%), respectively, increased risk of terminating breastfeeding at any given time after childbirth. Serum-PFAS concentrations were not associated with serum-prolactin concentrations. CONCLUSIONS: These findings are of public health importance due to the global exposures to PFAS. Because breastfeeding is crucial to promote both child health and maternal health, adverse PFAS effects on the ability to breastfeed may have long-term health consequences.
CONTEXT: Human exposure to perfluoroalkyl substances (PFAS) has been associated with reduced duration of breastfeeding, although not consistently so, and mechanisms by which PFAS might affect breastfeeding are unknown. OBJECTIVE: To examine the association between early pregnancy serum-PFAS concentrations and breastfeeding termination and to elucidate the potential role of serum-prolactin concentrations in pregnancy. MATERIALS AND METHODS: Pregnant women from the Odense Child Cohort provided blood samples for analysis of 5 major PFAS (n = 1300) and prolactin concentrations (n = 924). They subsequently provided information about the duration of breastfeeding in questionnaires at 3 and 18 months postpartum, and a subgroup also provided breastfeeding information via weekly cell phone text messages. Associations between serum-PFAS concentrations and breastfeeding termination were analyzed using Cox regressions, while linear regression was used to assess associations between serum-PFAS and prolactin concentrations. RESULTS: Increased serum concentrations of perfluorooctane sulfonic acid, perfluorooctanoic acid, perfluorononanoic acid, and ∑PFAS were associated with a 16% (95% CI: 4%-30%), 14% (95% CI: 2%-26%), 14% (95% CI: 3%-27%), and 20% (95% CI: 6%-36%), respectively, increased risk of terminating breastfeeding at any given time after childbirth. Serum-PFAS concentrations were not associated with serum-prolactin concentrations. CONCLUSIONS: These findings are of public health importance due to the global exposures to PFAS. Because breastfeeding is crucial to promote both child health and maternal health, adverse PFAS effects on the ability to breastfeed may have long-term health consequences.
Authors: Cesar G Victora; Rajiv Bahl; Aluísio J D Barros; Giovanny V A França; Susan Horton; Julia Krasevec; Simon Murch; Mari Jeeva Sankar; Neff Walker; Nigel C Rollins Journal: Lancet Date: 2016-01-30 Impact factor: 79.321
Authors: Sally S White; Jason P Stanko; Kayoko Kato; Antonia M Calafat; Erin P Hines; Suzanne E Fenton Journal: Environ Health Perspect Date: 2011-04-18 Impact factor: 9.031
Authors: Emma M Rosen; Anne Lise Brantsæter; Rachel Carroll; Line Haug; Alison B Singer; Shanshan Zhao; Kelly K Ferguson Journal: Environ Epidemiol Date: 2018-09
Authors: Klara Matouskova; Gillian K Szabo; Jessica Daum; Suzanne E Fenton; Sofie Christiansen; Ana M Soto; Jennifer E Kay; Bethsaida Cardona; Laura N Vandenberg Journal: Reprod Toxicol Date: 2022-06-25 Impact factor: 3.421
Authors: Fadil M Hannan; Taha Elajnaf; Laura N Vandenberg; Stephen H Kennedy; Rajesh V Thakker Journal: Nat Rev Endocrinol Date: 2022-10-03 Impact factor: 47.564